Uncategorized
SonoThera bags $125M series B to advance safer gene therapies
SonoThera bags $125M series B to advance safer gene therapies
Instead of using viral vectors, SonoThera’s genetic medicines are delivered through an ultrasound-mediated technology that could help sidestep key safety issues with conventional delivery methods. Read More